CRISPR Therapeutics AG 10-K for FY2020
CRISPR Therapeutics AG (CRSP)
10-K
2021-02-16
For: 2020-12-31
View Original
Added on
April 09, 2026
About this 10-K
CRISPR Therapeutics AG filed this 10-K on February 16, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $719K
- down 99.8% from $289.59M a year earlier
- Net loss
- $348.87M
- compared with net income of $66.86M a year earlier
- Diluted EPS
- -$5.29
- compared with $1.17 a year earlier